Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.
Mozaffar AznabNarges Eskandari RoozbahaniHoma MoazenPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
From a total of 288 patients (median age: 52 years (range 18-79), 112 (38.9%) males and 176 (61.1%) female) with different types of cancers, only two patients had an adverse effect of vaccination (including bone pain, runny nose, and fatigue), and one had COVID-19 ten days after vaccination. The rest of the patients did not show any side effects due to flu vaccination after one month of follow-up. Cancer patients are recommended to receive the flu vaccine annually during the pandemic and after the end of this pandemic, usually during the flu epidemic season to reduce mortality.